glp 1 articles Frontiers GLP-1 Medications and Their Place

The Wegovy prescribing information lists nausea, diarrhea, vomiting, constipation, and abdominal pain among common adverse reactions, and many GLP-1 nutrition resources recommend gentler textures and smaller servings

Overall, current data do not suggest a major increase in serious adverse events with dual therapy

When initiating semaglutide in patients already taking levothyroxine, clinicians may consider checking TSH levels 6-8 weeks after starting treatment, particularly for patients using oral semaglutide (Rybelsus) due to its documented effect on thyroxine exposure

Published online March 14, 2024

Heres a preview of the insights available in the full report learn how you can gain access here